HSBC Holdings’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $336M | Buy |
676,247
+20,804
| +3% | +$9.22M | 0.14% | 122 |
|
|
2026
Q1 | $293M | Buy |
655,443
+25,154
| +4% | +$11.7M | 0.15% | 119 |
|
|
2025
Q4 | $286M | Sell |
630,289
-7,043
| -1% | -$3.04M | 0.15% | 123 |
|
|
2025
Q3 | $249M | Sell |
637,332
-4,629
| -0.7% | -$1.93M | 0.14% | 135 |
|
|
2025
Q2 | $286M | Sell |
641,961
-202,714
| -24% | -$93.4M | 0.17% | 108 |
|
|
2025
Q1 | $409M | Sell |
844,675
-29,080
| -3% | -$13.6M | 0.25% | 66 |
|
|
2024
Q4 | $352M | Buy |
873,755
+18,739
| +2% | +$8.69M | 0.2% | 79 |
|
|
2024
Q3 | $397M | Sell |
855,016
-49,726
| -5% | -$23.9M | 0.23% | 70 |
|
|
2024
Q2 | $425M | Buy |
904,742
+98,800
| +12% | +$42.9M | 0.26% | 68 |
|
|
2024
Q1 | $337M | Buy |
805,942
+191,273
| +31% | +$80.9M | 0.23% | 80 |
|
|
2023
Q4 | $250M | Buy |
614,669
+53,862
| +10% | +$19.9M | 0.22% | 78 |
|
|
2023
Q3 | $195M | Sell |
560,807
-121,386
| -18% | -$42.5M | 0.2% | 83 |
|
|
2023
Q2 | $240M | Buy |
682,193
+118,878
| +21% | +$40.1M | 0.24% | 71 |
|
|
2023
Q1 | $177M | Buy |
563,315
+74,725
| +15% | +$22.4M | 0.21% | 87 |
|
|
2022
Q4 | $141M | Buy |
488,590
+176,722
| +57% | +$53.9M | 0.16% | 122 |
|
|
2022
Q3 | $90.9M | Sell |
311,868
-18,892
| -6% | -$5.44M | 0.15% | 118 |
|
|
2022
Q2 | $93.2M | Sell |
330,760
-17,468
| -5% | -$4.68M | 0.13% | 134 |
|
|
2022
Q1 | $90.5M | Sell |
348,228
-30,985
| -8% | -$7.35M | 0.11% | 159 |
|
|
2021
Q4 | $83.6M | Sell |
379,213
-21,846
| -5% | -$4.25M | 0.08% | 241 |
|
|
2021
Q3 | $72.9M | Buy |
401,059
+42,914
| +12% | +$8.38M | 0.07% | 234 |
|
|
2021
Q2 | $71.6M | Buy |
358,145
+56,678
| +19% | +$11.9M | 0.08% | 243 |
|
|
2021
Q1 | $64.7M | Sell |
301,467
-58,268
| -16% | -$12.8M | 0.08% | 260 |
|
|
2020
Q4 | $84.1M | Buy |
359,735
+61,071
| +20% | +$14M | 0.11% | 169 |
|
|
2020
Q3 | $81.3M | Buy |
298,664
+74,598
| +33% | +$20.6M | 0.13% | 137 |
|
|
2020
Q2 | $65M | Sell |
224,066
-2,983
| -1% | -$809K | 0.12% | 140 |
|
|
2020
Q1 | $53.5M | Buy |
227,049
+16,710
| +8% | +$3.83M | 0.12% | 153 |
|
|
2019
Q4 | $47M | Sell |
210,339
-64,040
| -23% | -$13M | 0.08% | 235 |
|
|
2019
Q3 | $46.5M | Buy |
274,379
+22,616
| +9% | +$4M | 0.09% | 241 |
|
|
2019
Q2 | $46.2M | Buy |
251,763
+93,849
| +59% | +$16.4M | 0.09% | 226 |
|
|
2019
Q1 | $29M | Buy |
157,914
+12,924
| +9% | +$2.39M | 0.05% | 365 |
|
|
2018
Q4 | $23.8M | Sell |
144,990
-66,863
| -32% | -$11.6M | 0.04% | 430 |
|
|
2018
Q3 | $40.8M | Buy |
211,853
+17,772
| +9% | +$3.16M | 0.07% | 294 |
|
|
2018
Q2 | $33M | Sell |
194,081
-86,920
| -31% | -$13.5M | 0.06% | 326 |
|
|
2018
Q1 | $45.8M | Buy |
281,001
+29,050
| +12% | +$4.74M | 0.07% | 279 |
|
|
2017
Q4 | $37.8M | Sell |
251,951
-61,476
| -20% | -$9.1M | 0.05% | 326 |
|
|
2017
Q3 | $47.7M | Buy |
313,427
+57,668
| +23% | +$8.68M | 0.08% | 244 |
|
|
2017
Q2 | $33M | Buy |
255,759
+110,408
| +76% | +$13.3M | 0.06% | 331 |
|
|
2017
Q1 | $15.9M | Buy |
145,351
+18,067
| +14% | +$1.59M | 0.03% | 542 |
|
|
2016
Q4 | $9.38M | Buy |
127,284
+18,676
| +17% | +$1.52M | 0.02% | 748 |
|
|
2016
Q3 | $9.47M | Buy |
108,608
+4,288
| +4% | +$405K | 0.02% | 697 |
|
|
2016
Q2 | $8.97M | Sell |
104,320
-20,448
| -16% | -$1.77M | 0.02% | 692 |
|
|
2016
Q1 | $9.92M | Buy |
124,768
+8,888
| +8% | +$804K | 0.03% | 646 |
|
|
2015
Q4 | $14.6M | Sell |
115,880
-47,648
| -29% | -$5.75M | 0.04% | 551 |
|
|
2015
Q3 | $17M | Sell |
163,528
-297,223
| -65% | -$38.2M | 0.04% | 443 |
|
|
2015
Q2 | $56.9M | Buy |
460,751
+189,921
| +70% | +$23.9M | 0.12% | 191 |
|
|
2015
Q1 | $32M | Buy |
270,830
+22,799
| +9% | +$2.73M | 0.06% | 315 |
|
|
2014
Q4 | $29.5M | Sell |
248,031
-50,455
| -17% | -$5.68M | 0.06% | 326 |
|
|
2014
Q3 | $33.6M | Buy |
298,486
+100,336
| +51% | +$9.55M | 0.07% | 277 |
|
|
2014
Q2 | $18.7M | Buy |
198,150
+15,559
| +9% | +$1.09M | 0.04% | 436 |
|
|
2014
Q1 | $12.8M | Buy |
182,591
+32,893
| +22% | +$2.61M | 0.03% | 489 |
|
|
2013
Q4 | $11.1M | Buy |
149,698
+29,747
| +25% | +$2.07M | 0.03% | 591 |
|
|
2013
Q3 | $9.1M | Buy |
119,951
+114,306
| +2,025% | +$9.1M | 0.02% | 640 |
|
|
2013
Q2 | $451K | Buy |
+5,645
| New | +$416K | ﹤0.01% | 1226 |
|
Other funds holding VRTX
HSBC Holdings's VRTX Position: Q2 2026 in Review
HSBC Holdings increased its Vertex Pharmaceuticals (VRTX) stake by 3.2% in Q2 2026, buying an estimated $9.22M and bringing the position to 676,247 shares worth $336M. The position accounts for 0.14% of the portfolio, ranked #122.
HSBC Holdings first reported a position in VRTX in Q2 2013 and has held it in 53 quarters since. The position peaked at $425M in Q2 2024. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- HSBC Holdings held 676,247 shares of Vertex Pharmaceuticals worth $336M as of Q2 2026.
- HSBC Holdings bought 20,804 Vertex Pharmaceuticals shares in Q2 2026, an estimated $9.22M.
- Vertex Pharmaceuticals made up 0.14% of HSBC Holdings's portfolio in Q2 2026, its #122 holding.
- HSBC Holdings first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- HSBC Holdings's Vertex Pharmaceuticals position peaked at $425M in Q2 2024.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.